Anti-CD137 provides co-stimulation signaling to enhance T cell proliferation and the specificity to target responding tumor cells, and anti-PD-L1 could block the interaction between PD-L1 and PD-1 to prevent PD-1 mediated T-cell exhaustion in melanoma [308]. Here, CD274 is linked to neoplasm.